423 related articles for article (PubMed ID: 19074479)
1. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials.
Philip M; Benatar M; Fisher M; Savitz SI
Stroke; 2009 Feb; 40(2):577-81. PubMed ID: 19074479
[TBL] [Abstract][Full Text] [Related]
2. A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke.
Savitz SI
Exp Neurol; 2007 May; 205(1):20-5. PubMed ID: 17408618
[TBL] [Abstract][Full Text] [Related]
3. On the analysis and interpretation of outcome measures in stroke clinical trials: lessons from the SAINT I study of NXY-059 for acute ischemic stroke.
Koziol JA; Feng AC
Stroke; 2006 Oct; 37(10):2644-7. PubMed ID: 16946150
[TBL] [Abstract][Full Text] [Related]
4. NXY-059: review of neuroprotective potential for acute stroke.
Fong JJ; Rhoney DH
Ann Pharmacother; 2006 Mar; 40(3):461-71. PubMed ID: 16507608
[TBL] [Abstract][Full Text] [Related]
5. The 2007 Feinberg lecture: a new road map for neuroprotection.
Donnan GA
Stroke; 2008 Jan; 39(1):242. PubMed ID: 18048866
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection in cerebral ischemia: emphasis on the SAINT trial.
Chacon MR; Jensen MB; Sattin JA; Zivin JA
Curr Cardiol Rep; 2008 Feb; 10(1):37-42. PubMed ID: 18416999
[TBL] [Abstract][Full Text] [Related]
7. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
Savitz SI; Fisher M
Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989
[TBL] [Abstract][Full Text] [Related]
8. Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke.
Feuerstein GZ; Zaleska MM; Krams M; Wang X; Day M; Rutkowski JL; Finklestein SP; Pangalos MN; Poole M; Stiles GL; Ruffolo RR; Walsh FL
J Cereb Blood Flow Metab; 2008 Jan; 28(1):217-9. PubMed ID: 17579658
[TBL] [Abstract][Full Text] [Related]
9. SAINT-I worked, but the neuroprotectant is not NXY-059.
Proctor PH; Tamborello LP
Stroke; 2007 Oct; 38(10):e109; author reply e110. PubMed ID: 17717310
[No Abstract] [Full Text] [Related]
10. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
11. NXY-059 for acute ischemic stroke.
Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
[TBL] [Abstract][Full Text] [Related]
12. Life after cerovive: a personal perspective on ischemic neuroprotection in the post-NXY-059 era.
Ginsberg MD
Stroke; 2007 Jun; 38(6):1967-72. PubMed ID: 17478741
[TBL] [Abstract][Full Text] [Related]
13. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
Diener HC; Lees KR; Lyden P; Grotta J; Davalos A; Davis SM; Shuaib A; Ashwood T; Wasiewski W; Alderfer V; Hårdemark HG; Rodichok L;
Stroke; 2008 Jun; 39(6):1751-8. PubMed ID: 18369171
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic strategies for the treatment of stroke.
Green AR; Shuaib A
Drug Discov Today; 2006 Aug; 11(15-16):681-93. PubMed ID: 16846795
[TBL] [Abstract][Full Text] [Related]
15. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
Lestage P; Lockhart B; Roger A
Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
[TBL] [Abstract][Full Text] [Related]
16. Emerging neuroprotective drugs for the treatment of acute ischaemic stroke.
Schmidt A; Minnerup J; Kleinschnitz C
Expert Opin Emerg Drugs; 2013 Jun; 18(2):109-20. PubMed ID: 23600899
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection in the SAINT-II aftermath.
Hermann DM; Bassetti CL
Ann Neurol; 2007 Dec; 62(6):677-8; author reply 678. PubMed ID: 17849454
[No Abstract] [Full Text] [Related]
18. Methodological quality of animal studies on neuroprotection in focal cerebral ischaemia.
van der Worp HB; de Haan P; Morrema E; Kalkman CJ
J Neurol; 2005 Sep; 252(9):1108-14. PubMed ID: 16170651
[TBL] [Abstract][Full Text] [Related]
19. [Development of new stroke therapies: outlook for neuroprotective drugs].
Rogalewski A; Schäbitz WR
Nervenarzt; 2008 Feb; 79(2):218-24. PubMed ID: 18214414
[TBL] [Abstract][Full Text] [Related]
20. NXY-059: a hopeful sign in the treatment of stroke.
Hess DC
Stroke; 2006 Oct; 37(10):2649-50. PubMed ID: 16946156
[No Abstract] [Full Text] [Related]
[Next] [New Search]
